Compositional, structural, and functional alterations in pulmonary surfactant in surgical patients after the early onset of systemic inflammatory response syndrome or sepsis

Critical Care Medicine

Volumn 27, Issue 1, 1999, Pages 82-89

  Raymondos, Konstantinos ^a   Leuwer, Martin ^a   Haslam, Patricia L ^b   Vangerow, Burckhardt ^a   Ensink, Marco ^a   Tschorn, Harald ^a   Schürmann, Wolfgang ^a   Husstedt, Hartmut ^a   Rueckoldt, Horst ^a   Piepenbrock, Siegfried ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Acute respiratory distress syndrome; Bronchoalveolar lavage; Infection; Lung injury; Postoperative course; Pulmonary surfactant; Sepsis; Surgery; Systemic inflammatory response syndrome

Indexed keywords

LUNG SURFACTANT; SURFACTANT PROTEIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INJURY SCALE; INTENSIVE CARE; LUNG ALVEOLUS SURFACE TENSION; LUNG INJURY; LUNG LAVAGE; MALE; MORTALITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SEPSIS; SURGICAL PATIENT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; APACHE; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, ADULT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0032894712     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199901000-00031     Document Type: Article

References (43)

1. 1. Hallman M, Spragg R, Harrell JH, et al: Evidence of lung surfactant abnormality in respiratory failure. J Clin Invest 1982; 70:673-683
2. 2. Pison U, Seeger W, Buchhorn R, et al: Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am Rev Respir Dis 1989; 140:1033-1039
3. 3. Pison U, Obertacke U, Brand M, et al: Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure. J Trauma 1990; 30:19-26
4. 4. Gregory TJ, Longmore WJ, Moxley MA, et al: Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991; 88:1976-1981
5. 5. Pison U, Obertacke U, Seeger W, et al: Surfactant protein A (SP-A) is decreased in acute parenchymal lung injury associated with polytrauma. Eur J Clin Invest 1992; 22:712-718
6. 6. Veldhuizen RA, McCaig LA, Akino T, et al: Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995; 152:1867-1871
7. 7. Günther A, Siebert C, Schmidt R, et al: Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 1996; 153: 176-184
8. 8. Haslam PL: Surfactant system in lung injury. In: ARDS Acute Respiratory Distress in Adults. Evans TW, Haslett C (Eds). London, Chapman & Hall, 1996, pp 263-296
9. 9. Kresch MJ, Lin WH, Thrall RS: Surfactant replacement therapy. Thorax 1996; 51:1137-1154
10. 10. Bredenberg CE, Paskanik AM, Nieman GF: High surface tension pulmonary edema. J Surg Res 1983; 34:515-523
11. 11. Garber BG, Hébert PC, Yelle JD, et al: Adult respiratory distress syndrome: A systemic overview of incidence and risk factors. Crit Care Med 1996; 24: 687-695
12. 12. Montgomery AB, Stager MA, Carrico CJ, et al: Causes of mortality in patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985; 132:485-489
13. 13. Bone RC, Balk RA, Cerra FB, et al: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis. Chest 1992; 101:1644-1655
14. 14. Murray JF, Matthay MA, Luce JM, et al: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720-723
15. 15. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824
16. 16. Putensen C: Volume-controlled versus biphasic positive airway pressure. Crit Care Med 1997; 25:203-205
17. 17. Gould MK, Ruoss SJ, Risk NW, et al: Indices of hypoxemia in patients with acute respiratory distress syndrome: Reliability, validity, and clinical usefulness. Crit Care Med 1997; 25:6-8
18. 18. Knaus WA, Wagner DP, Draper EA, et al: The APACHE III prognostic system: Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100:1619-1636
19. 19. Castella X, Artigas A, Bion J, et al: A comparison of severity of illness scoring systems for intensive care unit patients: Results of a multicenter, multinational study. Crit Care Med 1995; 23:1327-1335
20. 20. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917
21. 21. Bartlett GR: Phosphorus assay in column chromatography. J Biol Chem 1959; 234:466-468
22. 22. Putz G, Goerke J, Clements JA: Surface activity of rabbit pulmonary surfactant subfractions at different concentrations in a captive bubble. J Appl Physiol 1994; 77:597-605
23. 23. Lowry OH, Rosebrough NJ, Farr AL, et al: Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193:265-275
24. 24. Hamm H, Lührs J, Guzman y Rotaeche J, et al: Elevated surfactant protein A in bronchoalveolar lavage fluids from sarcoidosis and hypersensitivity pneumonitis patients. Chest 1994; 106: 1766-1770
25. 25. Magoon MW, Wright JR, Baritussio A, et al: Subfractions of lung surfactant. Implications for metabolism and surface activity. Biochim Biophys Acta 1983; 750:18-31
26. 26. Shelley SA, Paciga JE, Balis JU: Purification of surfactant from lung washings and washings contaminated with blood constituents. Lipids 1977; 12:505-510
27. 27. Shelley SA, Paciga JE, Lowell NE, et al: Immunologically related multimeric forms of 30-40kda peptides associated with lung surfactant in various mammalian species. Biochim Biophys Acta 1985; 839:50-56
28. 28. Raymondos K, Martin-Carrera I, Bernhard W, et al: A method for the isolation and preparation of surfactant from tracheobronchial aspirates in infants and children for quantitative and pulsating bubble analysis. Eur J Clin Invest 1996; 26:983-988
29. 29. Enhorning G: Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 1977; 43:198-203
30. 30. Rubin DB, Wiener-Kronish JP, Murray JF, et al: Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest 1990; 86:474-480
31. 31. Ueda T, Ikegami M, Jobe A: Surfactant subtypes in vitro conversion, in vivo function, and effects of serum proteins. Am J Respir Crit Care Med 1994; 149:1254-1259
32. 32. McGowan FX, Ikegami M, del Nido PJ, et al: Cardiopulmonary bypass significantly reduces surfactant activity in children. J Thorac Cardiovasc Surg 1993; 106:968-977
33. 33. Lewis JF, Ikegami M, Jobe AH: Altered surfactant function and metabolism in rabbits with acute lung injury. J Appl Physiol 1990; 69:2303-2310
34. 11-antitrypsin in the control of extracellular surfactant metabolism. Am J Physiol 1995; 268: L438-L445
35. 35. Lee CT, Fein AM, Lippmann M, et al: Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N Engl J Med 1981; 304:192-196
36. 36. Higuchi R, Lewis J, Ikegami M: In vitro conversion of surfactant subtypes is altered in alveolar surfactant isolated from injured lungs. Am Rev Respir Dis 1992; 145:1416-1420
37. 37. Veldhuizen RA, Hearn SA, Lewis JF, et al: Surface-area cycling of different surfactant preparations: SP-A and SP-B are essential for large-aggregate integrity. Biochem J 1994; 300:519-524
38. 38. Doyle IR, Nicholas TE, Bersten AD: Serum surfactant protein-A levels in patients with acute cardiogenic pulmonary edema and adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 152:307-317
39. 39. Suter PM, Suter S, Girardin E, et al: High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992; 145:1016-1022
40. 40. Wispé JR, Clark JC, Warner BB, et al: Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein. J Clin Invest 1990; 86:1954-1960
41. 41. Haslam PL, Postle AD, Raymondos K, et al: Measurement of pulmonary surfactant components and function in broncholaveolar lavage fluid. In: ERS task force report "Guidelines for Measurement of Acellular Components and Recommendations on Standardisation of Broncholalveolar Lavage (BAL). European Respiratory Review, In Press
42. 42. Yukitake K, Brow CL, Schlueter MA, et al: Surfactant apoprotein A modifies the inhibitory effect of plasma proteins on surfactant activity in vivo. Pediatr Res 1995; 37:21-25
43. 43. Strayer DS, Herting E, Sun B, et al: Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo. Am J Respir Crit Care Med 1996; 153:1116-1122